Bank of New York Mellon
IMA

Bank of New York Mellon’s ImageneBio Inc IMA Stock Holding History

Bank of New York Mellon’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,912
Closed -$101K – 4198
2024
Q1 		$101K Buy
5,912
+142
+2% +$2.59K ﹤0.01% 4035
2023
Q4 		$136K Hold
5,770
– – ﹤0.01% 4032
2023
Q3 		$300K Buy
5,770
+575
+11% +$34.6K ﹤0.01% 3799
2023
Q2 		$409K Buy
+5,195
New +$373K ﹤0.01% 3700
2022
Q2 		– Sell
-6,374
Closed -$466K – 4650
2022
Q1 		$466K Sell
6,374
-115
-2% -$12.2K ﹤0.01% 3748
2021
Q4 		$977K Buy
6,489
+4,583
+240% +$743K ﹤0.01% 3400
2021
Q3 		$288K Buy
1,906
+400
+27% +$58.1K ﹤0.01% 4057
2021
Q2 		$254K Buy
+1,506
New +$332K ﹤0.01% 4017

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon's IMA Position: Q2 2024 in Review

Bank of New York Mellon sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 5,912 shares — an estimated $101K sold.

Bank of New York Mellon first reported a position in IMA in Q2 2021 and held it in 8 quarters. The position peaked at $977K in Q4 2021. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

  • Bank of New York Mellon reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 5,912 ImageneBio Inc shares in Q2 2024, an estimated $101K.
  • Bank of New York Mellon first reported a position in ImageneBio Inc in Q2 2021 and held it in 8 quarters.
  • Bank of New York Mellon's ImageneBio Inc position peaked at $977K in Q4 2021.
  • 70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.